Effect of acetate on serum lipids in maintenance hemodialysis

Transactions - American Society for Artificial Internal Organs

Volumn 23, Issue 1, 1977, Pages 385-391

  Savdie, E ^a   Mahony, J F ^a   Stewart, J H ^a  

^a SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; BICARBONATE; CHOLESTEROL; FATTY ACID; TRIACYLGLYCEROL; ACETIC ACID; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HEMODIALYSIS; HUMAN; MALE; CASE REPORT; HYPERTRIGLYCERIDEMIA; KIDNEY; PREVENTION; THERAPY;

ACETATES; ADULT; BICARBONATES; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 0017620667     PISSN: 00660078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-197700230-00099     Document Type: Article

References (19)

1. Ibels, L.S., Simons, L.A., King, J.O., Williams, P.F., Neale, F.C., and Stewart, J.H. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation. Quart. J. Med., 601, 1975.
2. Cattran, D.C., Steiner, G., Fenten, S.S.A., and Wilson, D.R. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis. Trans. Am. Soc. Artif. Intern. Organs, 20-A:148, 1974.
3. Ibels, L.S., Reardon, M.F., and Nestel, P.J. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic hemodialysis patients and renal allograft recipients. J. Lab. Clin. Med., 87:648, 1976.
4. Gonzalez, F.M., Pearson, J.E., Garbus, S.B., and Holbert, R.D. On the effects of acetate during hemodialysis. Trans. Am. Soc. Artif. Intern. Organs, 20-A:169, 1974.
5. Tsaltas, T.T. and Friedman, E.A. Plasma lipid studies of uremic patients during hemodialysis. Am. J. Clin. Nutr., 21:430, 1968.
6. Yalow, R.S. and Berson, S.A. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest., 39:1157, 1960.
7. Boberg, J. and Carlson, L.A. Determination of heparin-induced lipoprotein lipase activity in human plasma. Clin. Chim. Acta, 10:420, 1964.
8. National Health and Medical Research Council. Dietary allowances for use in Australia. Government Publishing Service, Canberra, Australian Capital Territory, 1971, pp 18-19.
9. Snedecor, G.W. and Cochran, W.G. Statistical methods. Iowa State University Press, Ames, Iowa, 1967.
10. Rose, I.A., Grunberg-Manaqo, M., Korey, S.R., and Ocha, S. Enzymatic phosphorylation of acetate. J. Biol. Chem., 211:737, 1954.
11. Duncombe, W.G. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin. Chim. Acta, 9:122, 1964.
12. Coleman, J.E. Metabolic interrelationships between carbohydrates, lipids and proteins. Chapter in Diseases of Metabolism (Eds. P.K. Bondy and L.E. Rosenberg), W.B. Saunders Company, Philadelphia, London, Toronto, 1974, pp 107-220.
13. 14C-acetate during dialysis. Kidney Int., 10:198, 1976.
14. 14C] acetate in the perfused rat heart. Biochim. Biophys. Acta, 187:576, 1969.
15. Rorke, S.J., Shippey, W., and Davidson, W.D. Acetate delivery to hemodialysis patients. Kidney Int., 8:433, 1975.
16. Gutman, R.A., Uy, A., Shalhoub, R.J., Wade, A.D., O’Connell, J.M.B., and Recant, L. Hypertriglyceridemia in chronic non-nephrotic renal failure. Am. J. Clin. Nutr., 26:165, 1973.
17. Dombeck, D.H., Lindholm, D.D., and Vieira, J.A. Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy. Trans. Am. Soc. Artif. Intern. Organs, 19:150, 1973.
18. Grollman, A. The Functional Pathology of Disease, McGraw-Hill, New York, 1963, p 4.
19. Weights of insured persons in the United States associated with lowest mortality. Statis. Bull. Metrop. Life Insur. Co., 40:Nov-Dec, 1959.